HCCR-1 for detecting small hepatocellular carcinoma latent in a cirrhotic liver: a prospective cohort study
- PMID: 22851668
- PMCID: PMC3437781
- DOI: 10.1136/gutjnl-2012-301994
HCCR-1 for detecting small hepatocellular carcinoma latent in a cirrhotic liver: a prospective cohort study
Conflict of interest statement
Figures

Comment on
-
Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.Gut. 2012 Oct;61(10):1481-7. doi: 10.1136/gutjnl-2011-301862. Epub 2012 Jan 27. Gut. 2012. PMID: 22287594
Similar articles
-
Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10.Gut. 2013 Nov;62(11):1667-8. doi: 10.1136/gutjnl-2013-305164. Epub 2013 May 25. Gut. 2013. PMID: 23708586 Free PMC article. No abstract available.
-
A meta-analysis for percutaneous tumour ablation in patients with small hepatocellular carcinoma: highlighting combined strategy in the future.Gut. 2013 Mar;62(3):477-8. doi: 10.1136/gutjnl-2012-303584. Epub 2012 Sep 26. Gut. 2013. PMID: 23013726 No abstract available.
-
Comparison of MRI with liver-specific contrast agents and multidetector row CT for the detection of hepatocellular carcinoma: a meta-analysis of 15 direct comparative studies.Gut. 2013 Oct;62(10):1520-1. doi: 10.1136/gutjnl-2013-305231. Epub 2013 Aug 8. Gut. 2013. PMID: 23929696 No abstract available.
-
Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma.Intervirology. 2008;51 Suppl 1:42-5. doi: 10.1159/000122603. Epub 2008 Jun 10. Intervirology. 2008. PMID: 18544947 Review.
-
Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques.Adv Anat Pathol. 2011 Nov;18(6):438-45. doi: 10.1097/PAP.0b013e318234abb4. Adv Anat Pathol. 2011. PMID: 21993269 Review.
Cited by
-
Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.Oncotarget. 2015 Oct 6;6(30):29196-208. doi: 10.18632/oncotarget.5039. Oncotarget. 2015. PMID: 26470691 Free PMC article.
References
-
- Tremosini S, Forner A, Boix L, et al. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma. Gut. Published Online First: 27 January 2012. doi:10.1136/gutjnl-2011-301951 - DOI - PubMed
-
- Rimola J, Forner A, Tremosini S, et al. Non-invasive diagnosis of hepatocellular carcinoma <2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol 2012;56:1317–23 - PubMed
-
- Ko J, Lee YH, Hwang SY, et al. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. Oncogene 2003;22:4679–89 - PubMed
-
- Yoon SK, Lim NK, Ha SA, et al. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma. Cancer Res 2004;64:5434–41 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical